Literature DB >> 11343672

Long-term treatment of patients with inappropriate secretion of antidiuretic hormone by the vasopressin receptor antagonist conivaptan, urea, or furosemide.

G Decaux1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11343672     DOI： 10.1016/s0002-9343(01)00678-7

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  15 in total

1.  Hyponatremia: terminology and more.

Authors:  Guy Decaux; Wim Musch; Alain Soupart
Journal:  CMAJ       Date:  2004-06-22       Impact factor: 8.262

Review 2.  [Pharmacology and clinical relevance of vasopressin antagonists].

Authors:  R Lemmens-Gruber; M Kamyar
Journal:  Internist (Berl)       Date:  2008-05       Impact factor: 0.743

3.  Clinical management of SIADH.

Authors:  Peter Gross
Journal:  Ther Adv Endocrinol Metab       Date:  2012-04       Impact factor: 3.565

4.  Oral tolvaptan is safe and effective in chronic hyponatremia.

Authors:  Tomas Berl; Friederike Quittnat-Pelletier; Joseph G Verbalis; Robert W Schrier; Daniel G Bichet; John Ouyang; Frank S Czerwiec
Journal:  J Am Soc Nephrol       Date:  2010-02-25       Impact factor: 10.121

Review 5.  Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH).

Authors:  A Peri; N Pirozzi; G Parenti; F Festuccia; P Menè
Journal:  J Endocrinol Invest       Date:  2010-10-08       Impact factor: 4.256

6.  Management of hyponatremia in various clinical situations.

Authors:  Michael L Moritz; Juan C Ayus
Journal:  Curr Treat Options Neurol       Date:  2014-09       Impact factor: 3.598

7.  Current and future treatment options in SIADH.

Authors:  Robert Zietse; Nils van der Lubbe; Ewout J Hoorn
Journal:  NDT Plus       Date:  2009-11

8.  Conivaptan: Evidence supporting its therapeutic use in hyponatremia.

Authors:  Melissa Li-Ng; Joseph G Verbalis
Journal:  Core Evid       Date:  2010-06-15

Review 9.  Management of hyponatraemia in older people: old threats and new opportunities.

Authors:  Roy L Soiza; Hannah S C Talbot
Journal:  Ther Adv Drug Saf       Date:  2011-02

Review 10.  [Hyponatremia : The water-intolerant patient].

Authors:  J Hensen
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-08-23       Impact factor: 0.840
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.